Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Topical metformin gel is as effective and safe as steroids for treating alopecia areata.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Baricitinib is effective for severe alopecia areata but has some side effects.

Topical tofacitinib is effective and safe for treating alopecia areata.

PRP therapy effectively treats alopecia areata and atrophic acne scars.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Liposome-based cosmeceuticals improve treatment effectiveness for skin and hair conditions.

Lulican™ shampoo is more effective and better tolerated than Ketoconazole for treating scalp seborrheic dermatitis.

The FDA approved a new Pfizer drug for hair loss in teens.

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

Scalp micropigmentation effectively treats localized alopecia with high patient satisfaction.

Certain NK cell changes in blood may indicate alopecia areata progression.

CGF therapy may effectively treat psoriasis by reducing inflammation.

The 2940-nm Er: YAG laser combined with medication is a safe and better treatment for male hair loss than medication alone.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Shorter alopecia areata episodes lead to better baricitinib treatment outcomes.

Combining compound glycyrrhizin with minoxidil is more effective for alopecia areata than minoxidil alone.

MRI helps evaluate androgenetic alopecia severity.

Tofacitinib may work better than methotrexate for treating moderate-to-severe alopecia areata.

Regional prescribing of ritlecitinib mostly follows national guidance, but psychological assessments and consistent scoring need improvement.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib was more effective than methotrexate for treating alopecia areata.